Danaher Corporation $DHR is Dorsey Asset Management LLC’s 2nd Largest Position

Dorsey Asset Management LLC lowered its position in Danaher Corporation (NYSE:DHRFree Report) by 3.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 827,520 shares of the conglomerate’s stock after selling 33,330 shares during the quarter. Danaher makes up approximately 16.5% of Dorsey Asset Management LLC’s portfolio, making the stock its 2nd biggest position. Dorsey Asset Management LLC’s holdings in Danaher were worth $189,436,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in DHR. Bank Pictet & Cie Europe AG raised its stake in shares of Danaher by 25.4% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock worth $83,895,000 after purchasing an additional 74,301 shares during the last quarter. Maxi Investments CY Ltd purchased a new stake in shares of Danaher during the third quarter worth approximately $3,251,000. Northwestern Mutual Wealth Management Co. raised its stake in shares of Danaher by 303.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after purchasing an additional 186,584 shares during the last quarter. Defender Capital LLC. purchased a new stake in shares of Danaher during the fourth quarter worth approximately $35,715,000. Finally, CIBC Bancorp USA Inc. purchased a new stake in shares of Danaher during the third quarter worth approximately $17,480,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.3%

Shares of DHR stock opened at $181.57 on Wednesday. The business’s fifty day moving average price is $180.54 and its 200 day moving average price is $203.94. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The firm has a market capitalization of $128.51 billion, a PE ratio of 35.12, a P/E/G ratio of 2.31 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter in the prior year, the company posted $1.88 earnings per share. Danaher’s quarterly revenue was up 3.7% on a year-over-year basis. As a group, sell-side analysts forecast that Danaher Corporation will post 8.45 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio is 30.95%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Wells Fargo & Company cut their price target on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 22nd. Morgan Stanley cut their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. DZ Bank assumed coverage on Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target for the company. Jefferies Financial Group restated a “buy” rating and set a $245.00 price target on shares of Danaher in a research note on Tuesday, April 21st. Finally, UBS Group dropped their price objective on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and an average price target of $233.61.

Get Our Latest Report on Danaher

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.